Vanguard Group
GLSI icon

Vanguard Group’s Greenwich LifeSciences GLSI Stock Holding History

Vanguard Group’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.23M Buy
296,624
+14,443
+5% +$152K ﹤0.01% 3171
2025
Q3 		$2.81M Buy
282,181
+13,179
+5% +$149K ﹤0.01% 3465
2025
Q2 		$2.44M Sell
269,002
-1,304
-0.5% -$12.4K ﹤0.01% 3471
2025
Q1 		$2.58M Sell
270,306
-4,685
-2% -$56.8K ﹤0.01% 3401
2024
Q4 		$3.09M Buy
274,991
+1,466
+0.5% +$19.6K ﹤0.01% 3437
2024
Q3 		$3.93M Buy
273,525
+5,357
+2% +$79.4K ﹤0.01% 3357
2024
Q2 		$4.63M Buy
268,168
+45,066
+20% +$658K ﹤0.01% 3294
2024
Q1 		$4.45M Buy
223,102
+1,420
+0.6% +$17.5K ﹤0.01% 3344
2023
Q4 		$2.33M Buy
221,682
+1,729
+0.8% +$17.3K ﹤0.01% 3551
2023
Q3 		$1.94M Sell
219,953
-62,262
-22% -$585K ﹤0.01% 3595
2023
Q2 		$2.72M Sell
282,215
-70,109
-20% -$784K ﹤0.01% 3564
2023
Q1 		$4.86M Buy
352,324
+7,800
+2% +$124K ﹤0.01% 3316
2022
Q4 		$5.24M Buy
344,524
+88
+0% +$1.01K ﹤0.01% 3281
2022
Q3 		$3.13M Sell
344,436
-9,800
-3% -$90.7K ﹤0.01% 3565
2022
Q2 		$3M Sell
354,236
-20,964
-6% -$240K ﹤0.01% 3626
2022
Q1 		$7.36M Buy
375,200
+225,213
+150% +$4.55M ﹤0.01% 3311
2021
Q4 		$3.65M Buy
149,987
+693
+0.5% +$23.2K ﹤0.01% 3784
2021
Q3 		$5.83M Buy
149,294
+27,876
+23% +$1.16M ﹤0.01% 3558
2021
Q2 		$5.46M Buy
121,418
+15,157
+14% +$573K ﹤0.01% 3547
2021
Q1 		$3.62M Buy
106,261
+94,952
+840% +$3.23M ﹤0.01% 3683
2020
Q4 		$412K Buy
+11,309
New +$165K ﹤0.01% 3994

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vanguard Group's GLSI Position: Q4 2025 in Review

Vanguard Group increased its Greenwich LifeSciences (GLSI) stake by 5.1% in Q4 2025, buying an estimated $152K and bringing the position to 296,624 shares worth $6.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3171.

Vanguard Group first reported a position in GLSI in Q4 2020 and has held it in 21 quarters since. The position peaked at $7.36M in Q1 2022. 50 funds tracked by Wall St. Rank hold GLSI as of Q4 2025.

  • Vanguard Group held 296,624 shares of Greenwich LifeSciences worth $6.23M as of Q4 2025.
  • Vanguard Group bought 14,443 Greenwich LifeSciences shares in Q4 2025, an estimated $152K.
  • Greenwich LifeSciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3171 holding.
  • Vanguard Group first reported a position in Greenwich LifeSciences in Q4 2020 and has held it in 21 quarters since.
  • Vanguard Group's Greenwich LifeSciences position peaked at $7.36M in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.